Translink Corporate Finance advised Manetti & Roberts, a company controlled by Bolton Group, in the sale of the Somatoline brand to Olyos Group

Translink Corporate Finance teams in Italy and France acted as financial advisor to Manetti & Roberts, a company controlled by Bolton Group, in the sale of the Somatoline brand, a leading dermo-cosmetics brand in Italy, to Olyos, an international platform specialised in natural health and nutrition products.

Acquisition positions Somatoline for international expansion and future growth

Founded in 1973, Somatoline is a historic leading brand specialising in OTC products, cosmetics and health supplements in the pharmacy dermo-cosmetics segment. Somatoline offers a premium range and is known as the No. 1 slimming brand in pharmacies. Its products are distributed in more than 3,600 pharmacies and 600 parapharmacies, as well as online platforms. Somatoline is mainly available in Italy, France, Spain and Belgium, as well as indirectly distributed in Greece and Switzerland.

Olyos expands footprint in Southern Europe, adding €200M+ in revenue

With the acquisition of Somatoline, Olyos can now rely on 675 employees and revenues of over €200 million, further strengthening its presence in Southern Europe.

Controlled by Motion Equity Partners, a recognised private equity player with more than €1 billion of assets under management, Olyos has established itself as a key partner for pharmacies, which account for around 80% of its sales, while also using the e-commerce channel as a complementary route to market. The Group sells its products in more than 60 countries, notably through its local subsidiaries in Italy, Spain, Portugal, Costa Rica, Chile and Peru, and its extensive distributor network.

Comments from Translink Corporate Finance

“We are very pleased to have supported Manetti & Roberts in this transaction, which marks a new chapter in Somatoline’s development. Joining the Olyos Group provides the brand with an important international platform and strong growth prospects, thanks to the group’s deep expertise in the pharmacy sector and its presence in numerous markets. We believe this integration will allow Somatoline to further strengthen its premium positioning and accelerate its development both in Italy and internationally,” said Matteo Paggi, CEO of Translink Corporate Finance Italy.

Translink CF’s cross-border team composed of Matteo Paggi (Managing Partner), Riccardo Favero (Director), Matteo Buttinelli (Associate) and Pedro Carderelli (Analyst) from Translink CF Italy, and Antoine Tanguy (Partner) from Translink CF France.